Inventor · disambiguated record
Paul W. Manley
Also filed as: MANLEY PAUL W · MANLEY PAUL WILLIAM
71 granted patents·52 pending applications·1,043 citations·filing 1981–2018
99Inventor score
Top patents by PatentIndex Score
123 records- 0197US8026247B2Bicyclic amides as kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Sep 27, 2011·60 cites·3 claims
- 0296US7169791B2Inhibitors of tyrosine kinasesNOVARTIS AG·Filed 2003·Granted Jan 30, 2007·102 cites·11 claims
- 0395US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 0495US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0594US8163904B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-BenzamideMANLEY PAUL W·Filed 2006·Granted Apr 24, 2012·32 cites·4 claims
- 0694US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 0792US8389537B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Mar 5, 2013·17 cites·2 claims
- 0891US6410547B1Phenylpyridine derivatives useful as phosphodiesterase inhibitorsNOVARTIS AG·Filed 2001·Granted Jun 25, 2002·29 cites·13 claims
- 0990US7569566B2Inhibitors of tyrosine kinasesNOVARTIS AG·Filed 2008·Granted Aug 4, 2009·11 cites·7 claims
- 1089US8415363B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Apr 9, 2013·15 cites·8 claims
- 1189US7081532B2N-phenyl-2-pyrimidine-amine derivativesNOVARTIS AG·Filed 2001·Granted Jul 25, 2006·27 cites·2 claims
- 1289US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 1388US8580806B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Nov 12, 2013·9 cites·2 claims
- 1488US8343984B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2006·Granted Jan 1, 2013·11 cites·14 claims
- 1587US8604045B2Pyrimidylaminobenzamide derivatives for treatment of neurofibromatosisNOVARTIS AG·Filed 2012·Granted Dec 10, 2013·6 cites·2 claims
- 1687US7326699B24-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivativesNOVARTIS AG·Filed 2002·Granted Feb 5, 2008·28 cites·9 claims
- 1787US6258843B14-oxy-3-(aryl)phenyl-arylcarbonyloxy compounds useful as phosphodiesterase inhibitorsNOVARTIS AG·Filed 2000·Granted Jul 10, 2001·18 cites·13 claims
- 1886US9163005B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Oct 20, 2015·6 cites·1 claims
- 1986US8829195B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1DODD STEPHANIE KAY·Filed 2013·Granted Sep 9, 2014·16 cites·16 claims
- 2086US8829015B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Sep 9, 2014·7 cites·2 claims
- 2186US7855215B2Cyclic diaryl ureas suitable as tyrosine kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Dec 21, 2010·6 cites·19 claims
- 2286US7767688B2Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumoursNOVARTIS AG·Filed 2006·Granted Aug 3, 2010·10 cites·1 claims
- 2386US7122547B1Anthranilic acid amides and the use thereof as medicamentsNOVARTIS AG·Filed 1999·Granted Oct 17, 2006·79 cites·14 claims
- 2485US9340537B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted May 17, 2016·4 cites·3 claims
- 2585US9278981B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Mar 8, 2016·6 cites·18 claims
- 2685US7956053B2Inhibitors of tyrosine kinasesNOVARTIS AG·Filed 2009·Granted Jun 7, 2011·5 cites·7 claims
- 2785US6608071B2Isoquinoline derivatives with angiogenesis inhibiting activityNOVARTIS AG·Filed 2001·Granted Aug 19, 2003·24 cites·12 claims
- 2884US6686347B2Phthalazine derivatives for treating inflammatory diseasesNOVARTIS AG·Filed 2001·Granted Feb 3, 2004·18 cites·30 claims
- 2984US6624174B22-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 23, 2003·21 cites·15 claims
- 3084US4804658AImidazopyridine derivatives and pharmaceutical compositionsSEARLE & CO·Filed 1986·Granted Feb 14, 1989·33 cites·87 claims
- 3183US4837333ASubstituted alkylidene imidazolesSEARLE & CO·Filed 1987·Granted Jun 6, 1989·19 cites·2 claims
- 3283US4579862ACertain 1H-imidazol-1-yl-1-lower-alkanoic acid derivatives having anti-thrombotic activitySEARLE & CO·Filed 1983·Granted Apr 1, 1986·18 cites·17 claims
- 3382US7666874B2Pyrimidylaminobenzamide derivatives for hypereosinophilic syndromeNOVARTIS AG·Filed 2006·Granted Feb 23, 2010·6 cites·4 claims
- 3482US7652022B2Diaryl urea derivatives useful for the treatment of protein kinase dependent diseasesNOVARTIS AG·Filed 2003·Granted Jan 26, 2010·21 cites·9 claims
- 3581US8653093B2Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseasesALLAND LEILA·Filed 2010·Granted Feb 18, 2014·7 cites·3 claims
- 3680US8673930B2Pyrimidylaminobenzamide derivatives for systemic mastocytosisALLAND LEILA·Filed 2010·Granted Mar 18, 2014·6 cites·5 claims
- 3780US8119649B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2009·Granted Feb 21, 2012·1 cites·6 claims
- 3880US8093259B24-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanomaMANLEY PAUL W·Filed 2007·Granted Jan 10, 2012·6 cites·4 claims
- 3979US7329661B2N-phenyl-3-pyrimidine-amine derivativesNOVARTIS AG·Filed 2007·Granted Feb 12, 2008·4 cites·2 claims
- 4078US7399761B2Phthalazine derivatives with angiogenesis inhibiting activityNOVARTIS AG·Filed 2002·Granted Jul 15, 2008·8 cites·13 claims
- 4178US6090817APhenylpyridine derivatives useful as phosphodiesterase inhibitorsNOVARTIS AG·Filed 1997·Granted Jul 18, 2000·29 cites·18 claims
- 4277US7973031B2Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activityNOVARTIS AG·Filed 2002·Granted Jul 5, 2011·7 cites·6 claims
- 4376US8222244B2Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activityGRIFFIN JAMES D·Filed 2011·Granted Jul 17, 2012·4 cites·6 claims
- 4476US8034814B2Phthalazine derivatives with angiogenesis inhibiting activityNOVARTIS AG·Filed 2010·Granted Oct 11, 2011·2 cites·6 claims
- 4574US7482369B2Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Jan 27, 2009·1 cites·2 claims
- 4672US7329660B2Phthalazine derivatives for treating inflammatory diseasesNOVARTIS AG·Filed 2006·Granted Feb 12, 2008·1 cites·4 claims
- 4770US7312216B2N-phenyl-2-pyrimidine-amine derivativesNOVARTIS AG·Filed 2006·Granted Dec 25, 2007·1 cites·2 claims
- 4868US2007149539A1Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2007·Application pending·0 cites
- 4967US6706731B2Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinaseNOVARTIS AG·Filed 2001·Granted Mar 16, 2004·2 cites·20 claims
- 5066US8513256B2Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamideBUERGER HANS MICHAEL·Filed 2012·Granted Aug 20, 2013·1 cites·4 claims
Showing the top 50 of 123 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →